Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 5/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29259308 | 1.00 | LY96 (0.54) | LY96MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL31686199 | 0.87 | LY96 (0.67) | LY96MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL31686223 | 0.83 | SMN1; SMN2 (0.52) | LY96MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL30921742 | 0.83 | MAPT (0.55) | MEN1KMT2AMAPTSMN1; SMN2CYP1A2 | |
| SCHEMBL6851638 | 0.81 | CYP2C9 (0.62) | MEN1KMT2AMAPTSMN1; SMN2CYP1A2 | |
| SCHEMBL6851634 | 0.81 | CYP2C9 (0.62) | MEN1KMT2AMAPTSMN1; SMN2CYP1A2 | |
| SCHEMBL17899558 | 0.81 | ACHE (0.54) | LY96MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL29259516 | 0.78 | MEN1 (0.49) | MEN1KMT2AMAPTSMN1; SMN2CYP1A2 | |
| SCHEMBL6851585 | 0.78 | CYP1A2 (0.68) | MEN1KMT2AMAPTSMN1; SMN2CYP1A2 | |
| SCHEMBL6851587 | 0.78 | CYP1A2 (0.68) | MEN1KMT2AMAPTSMN1; SMN2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289786-A1 | CHLORINATED MONOCARBONYL CURCUMIN COMPOUNDS, PREPARATION METHOD, AND APPLICATION | SOUTHWEST MEDICAL UNIVERSITY (CN) | 2025-09-18 | — | — | US | disclosed |
| CN-118164904-A | Chloro-monocarbonyl curcumin compound and preparation method and application thereof | 西南医科大学 | 2024-06-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289786-A1 | CHLORINATED MONOCARBONYL CURCUMIN COMPOUNDS, PREPARATION METHOD, AND APPLICATION | DCK, IL1B, CLK4 | LY96 1515/4885MEN1 3248/4885KMT2A 1426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.